The FBI has launched an investigation into Huafon’s potential violation of a national security agreement with the Committee on Foreign Investment in the United States in connection with the Chinese chemicals company’s acquisition of DuPont’s biomaterials business. CFIUS approved the $240 million acquisition deal, which was finalized in May 2022, with the condition that Huafon...
